Encyclopedia

  • Comparative Pharmacodynamics and Plasma Concentrations of D-THREO-METHYLPHENIDATE HYDROCHLORIDE (cas 19262-68-1) After Single Doses of D-THREO-METHYLPHENIDATE HYDROCHLORIDE (cas 19262-68-1) and d,l-threo-Methylphenidate Hydrochloride in a Double-Blind, Placebo-Controlled, Crossover Laboratory School Study in Children With Attention-Deficit/Hyperactivity Disorder
  • Add time:08/01/2019         Source:sciencedirect.com

    ABSTRACTObjective:Methylphenidate has four optical isomers due to two asymmetries (erythro-threo and dextro-levo). The initial commercial formulation eliminated the erythro isomer, but the dextro-levo asymmetry was racemic, with equal amounts of d and l-threo isomers (d,l-MPH). Previous work has suggested that the d-threo isomer methylphenidate (d-MPH) rather than the l-threo isomer (l-MPH) is responsible for the clinical effects in children with attention-deficit/hyperactivity disorder (ADHD). This study compared the efficacy of acute equimolar doses of d-MPH and dl-MPH in reducing ADHD symptoms over an 8-hour period in a laboratory school setting and investigated the relationship of efficacy to plasma levels of MPH.

    We also recommend Trading Suppliers and Manufacturers of D-THREO-METHYLPHENIDATE HYDROCHLORIDE (cas 19262-68-1). Pls Click Website Link as below: cas 19262-68-1 suppliers


    Prev:Transdermal patches for D-threo-methylphenidate (free base): Formulation aspects and in vivo pharmacokinetics
    Next: A Double-Blind, Placebo-Controlled Trial of Dexmethylphenidate Hydrochloride and d,l-threo-Methylphenidate Hydrochloride in Children With Attention-Deficit/Hyperactivity Disorder)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View